Veru Inc. (VERU) financial statements (2020 and earlier)
Company profile
| Business Address |
48 NW 25TH STREET MIAMI, FL 33127 |
| State of Incorp. | WI |
| Fiscal Year End | September 30 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 TTM | 9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | 9/30/2015 | 9/30/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 4 | 3 | 2 | 4 | 6 | ||||
| Cash and cash equivalents | 4 | 3 | 2 | 4 | 6 | ||||
| Restricted cash and investments | 0 | 0 | 0 | 0 | |||||
| Receivables | 6 | 5 | 4 | 4 | 11 | 14 | 3 | ||
| Inventory, net of allowances, customer advances and progress billings | 5 | 4 | 2 | 3 | 2 | 2 | 3 | ||
| Inventory | 5 | 4 | 2 | 3 | 2 | 2 | 3 | ||
| Deferred tax assets | ✕ | ✕ | 2 | 1 | 1 | ||||
| Other undisclosed current assets | 6 | 8 | 1 | 1 | 1 | 1 | 1 | ||
| Total current assets: | 17 | 17 | 11 | 10 | 18 | 22 | 13 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 0 | 0 | 0 | 1 | 1 | 1 | 2 | ||
| Long-term investments and receivables | 8 | 8 | |||||||
| Accounts and financing receivable, after allowance for credit loss | 8 | 8 | |||||||
| Intangible assets, net (including goodwill) | 27 | 27 | 27 | 28 | |||||
| Goodwill | 7 | 7 | 7 | 7 | |||||
| Intangible assets, net (excluding goodwill) | 20 | 20 | 20 | 21 | |||||
| Deferred income tax assets | 9 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Other noncurrent assets | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||
| Deferred tax assets, net | ✕ | ✕ | 9 | 9 | 11 | 15 | 17 | ||
| Other undisclosed noncurrent assets | 8 | ||||||||
| Total noncurrent assets: | 38 | 37 | 37 | 45 | 20 | 16 | 19 | ||
| TOTAL ASSETS: | 55 | 54 | 48 | 55 | 39 | 37 | 32 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 4 | 3 | 4 | 3 | 1 | 2 | 2 | ||
| Accounts payable | 4 | 3 | 3 | 3 | 1 | 1 | 1 | ||
| Employee-related liabilities | 1 | 0 | 0 | 1 | 0 | ||||
| Debt | 7 | 5 | 7 | ||||||
| Deferred compensation liability | 1 | 2 | |||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 1 | |||||
| Other liabilities | 2 | 1 | 2 | 1 | 2 | 3 | 2 | ||
| Other undisclosed current liabilities | 3 | 2 | 1 | ||||||
| Total current liabilities: | 17 | 14 | 14 | 5 | 3 | 4 | 3 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 3 | 3 | 2 | ||||||
| Long-term debt, excluding current maturities | 2 | 3 | 2 | ||||||
| Finance lease, liability | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Operating lease, liability | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Liabilities, other than long-term debt | 0 | 0 | 1 | 1 | 1 | 0 | 0 | ||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 0 | 0 | 0 | |||
| Deferred rent credit | 0 | ✕ | ✕ | ✕ | ✕ | ||||
| Deferred tax liabilities, net | ✕ | ✕ | 1 | 0 | 0 | 0 | |||
| Deferred income tax liabilities | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Other liabilities | 0 | 0 | 0 | 1 | 1 | ||||
| Other undisclosed noncurrent liabilities | 5 | 4 | 3 | ||||||
| Total noncurrent liabilities: | 8 | 7 | 5 | 1 | 1 | 0 | 0 | ||
| Total liabilities: | 25 | 21 | 19 | 7 | 5 | 4 | 4 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 30 | 32 | 29 | 48 | 34 | 33 | 28 | ||
| Common stock | 1 | 1 | 1 | 1 | 0 | 0 | 0 | ||
| Treasury stock, value | (8) | (8) | (8) | (8) | (8) | (8) | (8) | ||
| Additional paid in capital | 111 | 110 | 95 | 91 | 70 | 69 | 68 | ||
| Accumulated other comprehensive loss | (1) | (1) | (1) | (1) | (1) | (1) | (1) | ||
| Accumulated deficit | (74) | (70) | (58) | (34) | (28) | (28) | (32) | ||
| Total stockholders' equity: | 30 | 32 | 29 | 48 | 34 | 33 | 28 | ||
| TOTAL LIABILITIES AND EQUITY: | 55 | 54 | 48 | 55 | 39 | 37 | 32 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 TTM | 9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | 9/30/2015 | 9/30/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 36 | 32 | 16 | 14 | 22 | 33 | 24 | |
| Revenue, net | ✕ | ✕ | ✕ | 14 | 22 | 33 | 24 | |
| Cost of revenue (Cost of Goods and Services Sold) | (12) | (10) | (7) | (7) | (9) | (14) | (11) | |
| Other undisclosed gross profit | 0 | 0 | ||||||
| Gross profit: | 24 | 22 | 9 | 7 | 13 | 19 | 13 | |
| Operating expenses | (31) | (28) | (30) | (16) | (10) | (12) | (9) | |
| Other operating income, net (Other Expenses) | 0 | |||||||
| Other undisclosed operating loss | (0) | |||||||
| Operating income (loss): | (7) | (6) | (21) | (8) | 3 | 7 | 4 | |
| Nonoperating income (expense) | (6) | (6) | (2) | (0) | (0) | 0 | 0 | |
| Investment income, nonoperating | (2) | (1) | 1 | |||||
| Foreign currency transaction gain (loss), before tax | (0) | (0) | (0) | (0) | (0) | 0 | (0) | |
| Other nonoperating income (expense) | 0 | 0 | (0) | (0) | (0) | 0 | ||
| Interest and debt expense | (5) | (5) | (3) | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (18) | (17) | (26) | (9) | 3 | 7 | 4 | |
| Other undisclosed income from continuing operations before income taxes | 5 | 5 | 3 | |||||
| Income (loss) from continuing operations before income taxes: | (14) | (12) | (23) | (9) | 3 | 7 | 4 | |
| Income tax expense (benefit) | 0 | 0 | (1) | 2 | (2) | (2) | (2) | |
| Net income (loss) attributable to parent: | (13) | (12) | (24) | (7) | 0 | 4 | 2 | |
| Preferred stock dividends and other adjustments | (2) | |||||||
| Net income (loss) available to common stockholders, diluted: | (13) | (12) | (24) | (9) | 0 | 4 | 2 | |
Comprehensive Income ($ in millions)
| 12/31/2019 TTM | 9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | 9/30/2015 | 9/30/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (13) | (12) | (24) | (7) | 0 | 4 | 2 | |
| Comprehensive income (loss), net of tax, attributable to parent: | (13) | (12) | (24) | (7) | 0 | 4 | 2 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.